Vistin Pharma ASA (FRA:VP4)

Market Cap	74.58M
Revenue (ttm)	38.85M
Net Income (ttm)	6.66M
Shares Out	n/a
EPS (ttm)	0.15
PE Ratio	11.20
Forward PE	n/a
Dividend	0.15 (8.96%)
Ex-Dividend Date	Jun 4, 2025

Volume	n/a
Average Volume	3,653
Open	1.675
Previous Close	1.710
Day's Range	1.675 - 1.675
52-Week Range	1.675 - 2.100
Beta	n/a
RSI	37.08
Earnings Date	Apr 24, 2026

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway.

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1969
• Employees: 75
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: VP4

Financial Performance

In 2024, Vistin Pharma ASA's revenue was 429.50 million, a decrease of -2.01% compared to the previous year's 438.33 million. Earnings were 62.75 million, an increase of 37.62%.

Financial numbers in NOK